Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HRT dosing regimens: continuous versus cyclic-pros and cons.

D Shoupe1

  • 1Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, USA.

International Journal of Fertility and Women'S Medicine
|April 11, 2001
PubMed
Summary

Newer hormone replacement therapy (HRT) regimens use lower estrogen doses to minimize side effects like vaginal bleeding. These individualized treatments improve patient compliance and confidence during menopausal management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hormone replacement therapy: consensus and controversies.

Panminerva medica·2014
Same author

Individualizing hormone-therapy according to cardiovascular risk.

Minerva ginecologica·2013
Same author

Individualizing hormone-therapy according to cardiovascular risk.

Minerva medica·2012
Same author

Comparison of estrogen and androgen levels after oral estrogen replacement therapy.

The Journal of reproductive medicine·2002
Same author

Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial.

Annals of internal medicine·2001
Same author

Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate.

Fertility and sterility·2001

Area of Science:

  • Endocrinology
  • Gynecology
  • Pharmacology

Background:

  • Hormone replacement therapy (HRT) is used for menopausal symptom management.
  • Vaginal bleeding is a significant side effect discouraging long-term HRT use.
  • Newer HRT formulations aim to reduce risks and side effects while improving compliance.

Purpose of the Study:

  • To review current HRT regimens, focusing on low-dose options.
  • To compare the efficacy and side effect profiles of continuous and cyclic HRT.
  • To highlight HRT's role in preventing bone loss and cardiovascular disease.

Main Methods:

  • Review of FDA-approved low-dose estrogen products for osteoporosis prevention.
  • Analysis of cyclic and continuous combined HRT regimens.

Related Experiment Videos

  • Comparison of side effect profiles, including vaginal bleeding and lipid changes.

    • Main Results:

    • Low-dose estrogen (e.g., 0.3 mg conjugated estrogen) is effective for bone and cardiovascular protection in menopausal women.
    • Cyclic low-dose estrogen therapy offers minimal progestin exposure and reduced bleeding.
    • Continuous combined regimens are simple and designed to minimize bleeding, though progestins may blunt estrogen's lipoprotein benefits.

    Conclusions:

    • Individualized HRT, utilizing low-dose and newer regimens, enhances patient outcomes.
    • Cyclic low-dose estrogen therapy presents advantages in side effect reduction and comfort.
    • Ongoing research explores HRT's mechanisms beyond lipid effects, particularly concerning progestin interactions.